Clever Leaves Holdings Inc Revenue Growth Rates (CLVR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Clever Leaves Holdings Inc   (NASDAQ: CLVR)
 

CLVR's Revenue Growth by Quarter and Year

Clever Leaves Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLVR Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December 4.91
3rd Quarter September 2.94
2nd Quarter June 4.73
1st Quarter March 3.98
FY 16.56





CLVR Revenue fourth quarter 2023 Y/Y Growth Comment
Clever Leaves Holdings Inc achieved in the fourth quarter 2023, above Company average Revenue improvement of 6.51% year on year, to $ 4.91 millions.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 116 other companies have achieved higher Revenue growth. While Clever Leaves Holdings Inc ' s Revenue increase of 6.51% ranks overall at the positon no. 1635 in the fourth quarter 2023.


CLVR Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December 6.51 % 10.02 % 25.07 % -
3rd Quarter September -11.18 % -17.87 % 2.81 % -
2nd Quarter June 1.5 % 26.98 % 89.18 % -
1st Quarter March -23.75 % 50 % 19.59 % -
FY   -6.97 % 15.81 % 26.82 % -

Financial Statements
Clever Leaves Holdings Inc 's fourth quarter 2023 Revenue $ 4.91 millions CLVR's Income Statement
Clever Leaves Holdings Inc 's fourth quarter 2022 Revenue $ 4.61 millions Quarterly CLVR's Income Statement


CLVR Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December 67.01 % 39.27 % 3.97 % -14.54 %
3rd Quarter September -37.84 % -28.97 % 9.81 % 102.06 %
2nd Quarter June 18.84 % -10.73 % 5.46 % -33.33 %
1st Quarter March -13.67 % 24.58 % 3.88 % -
FY (Year on Year)   -6.97 % 15.81 % 26.82 % -


Back to CLVR Growth rate Comparisons >> Back to CLVR Growth rate Comparisons >>


Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #117
Healthcare Sector #312
Overall #1635

Revenue Y/Y Growth Statistics
High Average Low
26.82 % -3.02 % -23.85 %
(Jun 30 2022)   (Mar 31 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #117
Healthcare Sector #312
Overall #1635
Revenue Y/Y Growth Statistics
High Average Low
26.82 % -3.02 % -23.85 %
(Jun 30 2022)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Clever Leaves Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
66.89 % 5.46 % -37.75 %
(Dec 31 2023)  


CLVR's IV. Quarter Q/Q Revenue Comment
Clever Leaves Holdings Inc achieved in the IV. Quarter 2023 above company average sequential Revenue jump of 67.01%, to $ 4.91 millions, from $2.94 millions in the third quarter.
CLVR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Clever Leaves Holdings Inc 's Revenue growth quarter on quarter, overall rank is 275.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #36
Healthcare Sector #78
Overall #275
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #36
Healthcare Sector #78
Overall #275
Revenue Q/Q Growth Statistics
High Average Low
66.89 % 5.46 % -37.75 %
(Dec 31 2023)  


CLVR's IV. Quarter Q/Q Revenue Comment
Clever Leaves Holdings Inc achieved in the IV. Quarter 2023 above company average sequential Revenue jump of 67.01%, to $ 4.91 millions, from $2.94 millions in the third quarter.
CLVR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Clever Leaves Holdings Inc 's Revenue growth quarter on quarter, overall rank is 275.


Clever Leaves Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 16.56 $ 16.26 $ 16.62 $ 16.55 $ 17.80
Y / Y Revenue Growth (TTM) -6.99 % -6.44 % -8.19 % -3.31 % 15.78 %
Year on Year Revenue Growth Overall Ranking # 44 # 122 # 138 # 137 # 0
Seqeuential Revenue Change (TTM) 1.82 % -2.18 % 0.42 % -7 % 2.42 %
Seq. Revenue Growth (TTM) Overall Ranking # 85 # 2926 # 991 # 940 # 739


Cumulative Revenue growth Comment
Clever Leaves Holdings Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -6.99% year on year, at Dec 31 2023 compare to the -6.44% decrease at Sep 30 2023. If the Clever Leaves Holdings Inc 's fiscal year would end at Dec 31 2023, annual Revenue would be $17 millions.

Among companies within the Healthcare sector 9 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 44, from total ranking in previous quarter at 122.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 10
Overall # 44

Revenue TTM Y/Y Growth Statistics
High Average Low
216.88 %
 143.54 %
-6.99 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 26
S&P 500 # 85
Cumulative Revenue growth Comment
Clever Leaves Holdings Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -6.99% year on year, at Dec 31 2023 compare to the -6.44% decrease at Sep 30 2023. If the Clever Leaves Holdings Inc 's fiscal year would end at Dec 31 2023, annual Revenue would be $17 millions.

Among companies within the Healthcare sector 9 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 44, from total ranking in previous quarter at 122.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 10
Overall # 44

Revenue TTM Y/Y Growth Statistics
High Average Low
216.88 %
143.54 %
-6.99 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 26
S&P 500 # 85




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLVR's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Enovis Corp11.33%$ 11.330 millions
Integer Holdings Corporation10.87%$ 10.870 millions
Ufp Technologies Inc 10.79%$ 10.785 millions
Concord Medical Services Holdings Ltd10.58%$ 10.585 millions
Myriad Genetics Inc 10.57%$ 10.574 millions
Warby Parker Inc 10.51%$ 10.510 millions
Merit Medical Systems Inc10.44%$ 10.442 millions
Sonida Senior Living Inc 10.41%$ 10.407 millions
Inotiv Inc 10.38%$ 10.384 millions
Stevanato Group S p a 10.34%$ 10.336 millions
Haemonetics Corporation10.23%$ 10.226 millions
Infusystem Holdings Inc10.20%$ 10.201 millions
Kamada Ltd 10.19%$ 10.190 millions
Sonendo Inc 10.01%$ 10.008 millions
Adapthealth Corp 9.99%$ 9.990 millions
Puma Biotechnology Inc 9.90%$ 9.902 millions
Bausch Health Companies Inc 9.80%$ 9.804 millions
Ironwood Pharmaceuticals inc 9.66%$ 9.659 millions
U S Physical Therapy Inc9.65%$ 9.646 millions
Edap Tms Sa9.64%$ 9.645 millions
Brookdale Senior Living Inc 9.58%$ 9.585 millions
Option Care Health Inc 9.52%$ 9.523 millions
Radnet Inc 9.51%$ 9.510 millions
Alpha Teknova Inc 9.45%$ 9.454 millions
Incyte Corporation9.35%$ 9.349 millions
Vertex Pharmaceuticals Inc9.34%$ 9.337 millions
Anika Therapeutics Inc 9.15%$ 9.151 millions
Semler Scientific inc 9.15%$ 9.148 millions
Bioventus Inc 9.11%$ 9.113 millions
Lineage Cell Therapeutics Inc 9.03%$ 9.034 millions


About Clever Leaves Holdings Inc Revenue Growth Rates (CLVR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Clever Leaves Holdings Inc (CIK 1819615).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001819615-24-000031
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Clever Leaves Holdings Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.